No Data
No Data
ENDRA Life Sciences Inc Trading Halted, Volatility Trading Pause
ENDRA Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Rule
Express News | ENDRA Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement
10-Q/A: Quarterly report (Amendment)
10-Q: Q3 2024 Earnings Report
8-K: ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update